EclipseBio
Eclipsebio was founded in 2017 in San Diego by RNA biologists and drug developers. We combine AI-powered sequence design, rapid prototyping, and sequencing-based analytics through our integrated eCOMPASS platform, and provide proprietary analytical technologies as individual capabilities for programs that need targeted support. Over 300 partners across pharma, biotech, and academia, including 80% of the top biopharma companies by revenue, trust our team to deliver insights they can act on.
